October 30, 2010 by staff
A company in Puerto Rico manufactures bottles for drug Lipitor. The smell is considered from the bottle, not the drug itself. The smell is compatible with the presence of a chemical called TBA found in wood preservatives used in shipping pallets. Pfizer said the smell is not likely to cause health problems in patients treated with Lipitor.
The recall was initiated by two consumer complaints about the odor bottles manufactured by a third in Puerto Rico.
Pfizer reports that they have thoroughly reviewed the center of the case, that exposure were sporadic bottles at low levels tribomanisole (TBA) as they are stored or shipped.
Pfizer has strengthened control of TBA odor problems earlier this year, Lipitor recalled lots packed and shipped before the changes were made in August.
Pfizer said more recalls could follow.
Lipitor is the number one selling drug in the world today. It works by suppressing an enzyme in the liver that is related to the production of cholesterol. Pfizer said the recall would not cause any kind of shortages.
Please feel free to send if you have any questions regarding this post , you can contact on
Disclaimer: The views expressed on this site are that of the authors and not necessarily that of U.S.S.POST.